ASX News Health Care US FDA awards Clarity Pharma’s novel prostate cancer PET scan imaging compound fast track status Clarity Pharmaceuticals (ASX:CU6) has revealed it's received fast track status from the US FDA for its… 2 mins22 August 2024 11:24 (AEST)